,i #aac? ,,congress #b;d ,session ,h4 ,r4 #dgdf ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,may #bh1 #bjad ,mrs4 ,c>olyn ,b4 ,maloney ( ,new ,york 7= h]self1 ,mr4 ,f>r1 & ,ms4 ,moore7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to am5d ! ,public ,heal? ,s]vice ,act to e/abli% a program ( rese>* reg>d+ ! risks pos$ by ! pres5ce ( diox91 syn!tic fib]s1 *emical fragrances1 & o!r compon5ts ( fem99e hygi5e products4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,rob9 ,danielson ,act ( #bjad4 #b4 ,f9d+s ,! ,congress f9ds z foll[s3 7#a7 ,fem99e hygi5e products are widely us$ by wom5 9 ! ,unit$ ,/ates today1 b !re is n en\gh rese>* on ! compon5ts ( ^! products4 7#b7 ,wom5 may be expos$ to sub/ances 9 tampons & o!r m5/rual products = z long z #fj ye>s ov] ! c\rse ( _! reproductive lives4 ,! av]age woman may use z _m z #af1hjj tampons 9 h] lifetime4 ,a woman on m5opausal hormone !rapy may use z _m z #bd1cfj tampons 9 h] lifetime4 7#c7 ,trace am\nts ( diox9s c be f\nd 9 tampons or o!r fem99e hygi5e products4 ,! ,environm5tal ,protection ,ag5cy & ! ,int]national ,ag5cy = ,rese>* on ,canc]1 an arm ( ! ,_w ,heal? ,organization1 h conclud$ t diox9s are a probable human c>c9og5 7canc]-caus+ ag5t74 7#d7 ,! ,food & ,drug ,adm9i/ration 7ref]r$ to 9 ?is section z ! ,,fda7 has hi/orically reli$ on data provid$ by manufactur]s ( fem99e hygi5e products 9 det]m9+ product safety4 7#e7 ,al?\gh ! ,,fda curr5tly requires tampon manufactur]s to r\t9ely monitor diox9 levels 9 raw mat]ials & f9i%$ tampons1 ?is in=mation is n readily available to ! public4 ,! ,,fda %\ld consid] :e!r to exp& regulation to include o!r types ( fem99e hygi5e products & a broad] li/ ( contam9ants4 #c4 ,rese>* on diox9 & o!r pot5tially h>mful compon5ts ( fem99e hygi5e products ,"p ,f ( title ,,iv ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bhg;d et seq47 is am5d$ by add+ at ! end ! foll[+ section3 #dhf;,c4 ,rese>* on diox9 & o!r pot5tially h>mful compon5ts ( fem99e hygi5e products 7a7 ,rese>* 7#a7 ,9 g5]al ,! ,director ( ,,nih1 9 collaboration ) ! ,director ( ! ,(fice1 %all provide = ! conduct or support ( rese>* to det]m9e ! ext5t to :i* ! pres5ce ( diox9s1 syn!tic fib]s1 *lor9e1 & o!r compon5ts1 includ+ contam9ants & sub/ances us$ z fragrances1 9 tampons & o!r fem99e hygi5e products-- 7,a7 poses any risks to ! heal? ( wom5 :o use ! products1 includ+ risks relat+ to c]vical canc]1 endometriosis1 inf]tility1 ov>ian canc]1 brea/ canc]1 immune sy/em defici5cies1 pelvic inflammatory disease1 toxic %ock syndrome1 & bact]ial & yea/ infections2 & 7,b7 poses any risks to ! heal? ( *ildr5 ( wom5 :o us$ su* products dur+ or be=e ! pregnancies involv$1 includ+ risks relat+ to fetal & *ildhood developm5t4 7#b7 ,requirem5t reg>d+ data f manufactur]s ,rese>* "u p>agraph 7#a7 %all include rese>* to confirm ! data on tampons & o!r fem99e hygi5e products submitt$ to ! ,commission] ( ,food & ,drugs by manufactur]s ( su* products4 7#c7 ,def9ition ,= purposes ( p>agraph 7#a71 ! t]m fem99e hygi5e products means tampons1 pads1 l9]s1 cups1 sponges1 & simil> products us$ by wom5 ) respect to m5/ruation or o!r g5ital-tract secretions4 7b7 ,reports ,reports on ! results ( rese>* "u subsection 7a7 %all be p]iodically submitt$ to ! ,congress1 ! ,commission] ( ,food & ,drugs1 ! ,adm9i/rator ( ! ,environm5tal ,protection ,ag5cy1 & ! ,*airman ( ! ,consum] ,product ,safety ,commission4 ,su* reports %all be made available to ! public ?r\gh ! data sy/em & cle>+h\se program e/abli%$ "u section #dhf;,a1 or ?r\gh o!r appropriate means4 7c7 ,au?orization ( appropriations ,= ! purpose ( c>ry+ out ?is section1 !re are au?oriz$ to be appropriat$ su* sums z may be necess>y = ea* ( ! fiscal ye>s #bjae ?r\gh #bjai4 4